17 completed, 3 unknown, 2 not yet recruiting, 1 terminated. 9 Phase 4, 5 Phase 2, 4 Phase 3, 3 Not applicable, 1 Early Phase 1.
Follow Ipratropium Bromide: new trials by email Literature Review of Ipratropium Bromide trials Research Report on Ipratropium Bromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD) Revefenacin, formoterol fumarate, Placebo (Sterile Normal Saline) - COPD Exacerbation | Phase 4 | Not yet recruiting | University of Tennessee Graduate School of Medicine | 280 | 2026-11-12 | 2026-10-19 |
| Effect of Ipratropium Bromide on EILO Ipratropium Bromide, Normal Saline (Placebo) - Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity | Phase 2 | Not yet recruiting | Cook Children's Health Care System | 50 | 2026-06-01 | 2026-05-05 |
| Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) Salbutamol, Ipratropium Bromide, Salbutamol plus Ipratropium Bromide - Asthma, Airway Obstruction | Not applicable | Unknown | Hat Yai Medical Education Center | 60 | 2024-02-17 | 2024-02-20 |
| Treating Respiratory Emergencies in Children Study Ipratropium Bromide - Asthma in Children | Phase 2 | Completed | Oregon Health and Science University | 44 | 2024-01-19 | 2026-04-24 |
| Revefenacin in Acute Respiratory Insufficiency in COPD Revefenacin Inhalation Solution [Yupelri], Ipratropium Bromide - COPD, Acute Respiratory Failure | Phase 2 | Completed | University of California, Los Angeles | 21 | 2020-11-01 | 2026-10-14 |
| Ipratropium Bromide Spray as Treatment for Sialorrhea in Children Ipratropium bromide, Placebo - Sialorrhea | Phase 2 | Unknown | London Health Sciences Centre | 30 | 2019-01-01 | 2018-11-21 |
| Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease Ipratropium Bromide, Flexible Bronchoscopy/Biopsy - Lung Diseases, Interstitial | Completed | GlaxoSmithKline | 8 | 2017-11-21 | 2019-01-29 | |
| Defining and Treating Depression-related Asthma Ipratropium Bromide - Asthma, Depression | Early Phase 1 | Completed | State University of New York at Buffalo | 39 | 2016-09-09 | 2026-04-23 |
| Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation Nebulized Magnesium Sulfate, Nebulized isotonic saline, Nebulized Salbutamol - Asthma | Phase 4 | Unknown | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | 152 | 2015-09-01 | 2015-12-02 |
| Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD Placebo, ipratropium bromide, salbutamol - Chronic Obstructive Pulmonary Disease (COPD) | Not applicable | Completed | Zhujiang Hospital | 22 | 2014-12-01 | 2015-07-28 |
| Ipratropium Bromide in Peri-Operative COPD placebo, ipratropium bromide - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | Boehringer Ingelheim | 192 | 2013-10-01 | 2016-10-25 |
| Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes ipratropium bromide, Placebo - Bronchospasm, Exercise-Induced | Phase 4 | Completed | University of California, San Francisco | 20 | 2012-12-01 | 2020-06-05 |
| Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study EP-101 via nebulizer (eFlow®) 25 ug, EP-101 via nebulizer (eFlow®) 50 ug, EP-101 via nebulizer (eFlow®) 100 ug - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Sunovion Respiratory Development Inc. | 140 | 2011-08-01 | 2018-05-09 |
| Actuation Indicator Trial in Patients With COPD Ipratropium bromide - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 142 | 2009-06-01 | 2014-07-02 |
| Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD) ipratropium bromide, placebo, constant rate step test - Chronic Obstructive Pulmonary Disease | Not applicable | Completed | Laval University | 44 | 2008-10-01 | 2011-02-09 |
| Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients Salbutamol, ipratropium bromide - COPD | Phase 4 | Completed | University Hospital, Antwerp | 6 | 2008-06-01 | 2009-06-02 |
| Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness ipratropium bromide, placebo - Asthma | Phase 4 | Completed | University of Saskatchewan | 12 | 2008-01-01 | 2009-01-07 |
| Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. Budesonide, albuterol, Ipratropium bromide - Asthma | Phase 3 | Completed | Northwell Health | 95 | 2007-09-01 | 2016-01-21 |
| Budesonide Inhalation Suspension for Acute Asthma in Children Budesonide inhalation suspension (0.5 mg/2mL) 2mg, albuterol (5mg/mL) 7.5 or 10mg, Prednisolone, prednisone, or methylprednisolone, Albuterol, ipratropium bromide - Asthma, Acute Asthma | Phase 4 | Completed | Children's Hospital of Philadelphia | 179 | 2006-12-01 | 2012-08-10 |
| Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD) Ipratropium Bromide - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Queen's University | 32 | 2005-07-01 | 2011-04-19 |
Showing 20 of 23. Sign in to see all of them.
Pulmonary Disease, Chronic Obstructive (9) · Asthma (7) · Emergencies (2) · Motor Activity (2) · Airway Obstruction (1) · Airway Remodeling (1) · Asthma, Exercise-Induced (1) · Autonomic Nervous System Diseases (1) · Bronchiolitis Obliterans Syndrome (1) · Depression (1) · Disease (1) · Dyspnea (1) · Lung Diseases, Interstitial (1) · Sialorrhea (1)
Boehringer Ingelheim (4) · Children's Hospital of Philadelphia (1) · Cook Children's Health Care System (1) · GlaxoSmithKline (1) · Hat Yai Medical Education Center (1) · Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1) · Laval University (1) · London Health Sciences Centre (1) · Northwell Health (1) · Oregon Health and Science University (1) · Queen's University (1) · State University of New York at Buffalo (1) · Sunovion Respiratory Development Inc. (1) · University Hospital, Antwerp (1) · University of California, Los Angeles (1)
United States (10) · Canada (3) · China (2) · United Kingdom (2) · Belgium (1) · Mexico (1) · Thailand (1) · Tunisia (1)
Ahmet Tutuncu, M.D., Ph.D. (1) · Bryan D. Upham, M.D. (1) · Chen Xin, Doctor (1) · Cynthia J Mollen, M.D. (1) · Denis E O'Donnell, MD (1) · Donald Tashkin, MD (1) · Donald W Cockcroft, MD (1) · Heather K Lehman, MD (1) · Igor Z Barjaktarevic, MD, PhD (1) · Julie Strychowsky, MD (1)
PMID 11113831, PMID 11825832, PMID 19496252, PMID 22509905, PMID 35546672, PMID 41943480
UL1TR001412 (1)